{
    "title": "Drugmaker Novo Nordisk warns of U.S. legislation, cautious on 2018",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5038519/Drugmaker-Novo-Nordisk-warns-U-S-legislation-cautious-2018.html",
    "date": "2017-11-01",
    "keywords": [
        "growth",
        "year",
        "percent",
        "nordisk",
        "profit",
        "legislation",
        "operating",
        "drug",
        "jacobsen",
        "business",
        "market",
        "state",
        "industry",
        "jorgensen",
        "level",
        "share",
        "thirdquarter",
        "injection",
        "term",
        "label",
        "copenhagen",
        "forecast",
        "draft",
        "pricing",
        "transparent",
        "warning",
        "president",
        "trump",
        "number",
        "murder",
        "executive",
        "company",
        "clarity",
        "transparency",
        "disclosure",
        "instance",
        "maker",
        "gmt",
        "back",
        "guidance",
        "tresiba",
        "levemir",
        "range",
        "outlook",
        "line",
        "price",
        "obesity",
        "version",
        "money",
        "bestseller",
        "trulicity",
        "trend",
        "victozas",
        "claim",
        "risk",
        "glp1",
        "imitation",
        "hormone",
        "production",
        "insulin",
        "novo",
        "aim",
        "semaglutide",
        "december",
        "ammunition",
        "firm",
        "poll",
        "editing",
        "louise",
        "weir"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}